FDA NDC Directory · JSON-LD · Markdown

FLUDEOXYGLUCOSE F-18

NDC 78714-001 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerBarbara Ann Karmanos Cancer Hospital
Marketing categoryAbbreviated NDA (generic) · App ANDA204385
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsFLUDEOXYGLUCOSE F-18 (300 mCi/mL)
Marketing started20200131
Package count1

External sources

Source: openFDA. Public-domain (CC0).